Generic Name and Formulations:
Azelaic acid 15%; aqueous gel; contains propylene glycol.
Indications for FINACEA:
Wash and dry skin. Massage thin layer gently into affected areas twice daily (AM & PM). May apply cosmetics after gel dries.
Monitor patients with dark complexions for hypopigmentation. Discontinue if sensitivity or severe irritation develops. Avoid eyes, mouth, other mucous membranes, occlusive dressings, topical alcoholic products, abrasives, peeling agents. Reevaluate if no improvement after 12 weeks of treatment. Foam: flammable. Pregnancy (Cat.B). Nursing mothers.
Burning, stinging, tingling, pruritus, scaling, dry skin, xerosis, erythema, irritation, edema, contact dermatitis, acne; worsening of asthma; foam: also application site pain.
Gel—50g tubes; Foam—50g cans
Clinical Pain Advisor Articles
- Brain Plasticity in Patients With Complex Regional Pain Syndrome
- Perturbation-Based Rehabilitation Effective for Chronic Low Back Pain
- IBS-Associated Chronic Pain: Formulation of Core Diagnostic Criteria
- Fluoroscopically Guided Sacroiliac Interventions: Appropriate Use Criteria
- Cannabis Use Associated With Relationship Between Pain and Negative Affect
- Cannabis Use Associated With Aberrant Drug Behaviors
- Walgreens to Carry Naloxone in All Pharmacies to Combat Drug Abuse
- Independent Pharmacies Expanding Services Available to Patients
- Ketamine Exhibits Effective Pain Relief for Refractory Headaches
- Pain In Elite Athletes: IOC Recommendations on Contributing Factors and Treatment Approach
- Naproxen Plus Muscle Relaxants vs Naproxen Monotherapy for Low Back Pain
- Pain Processing: Examining the Role of Oxytocin
- Short- vs Long-Acting Opioids for Osteoarthritis Pain
- Extended-Release Naltrexone Injections Reduce Opioid Dependence
- Depressive Symptoms in Medical Interns Increased With Work-Family Conflicts